Public trial registry of the CCC-Munich

Trial NiTraSarc

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
NiTraSarc
World
Full title
:

Kombinierte Behandlung mit Nivolumab und Trabectedin bei Patienten mit metastasierten oder inoperablen Weichteilsarkomen – Die Phase-II-Studie NiTraSarc

World
EudraCT number
:
2017-001083-38
World
NCT number
:
NCT03590210
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Indications
Classification Code Description
- C40-C41 Sarcoma
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
II
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2022-10-31 / 2020-02-07
Participants
Function Prename Surname Organization
Printer
 
Application_get